Your session is about to expire
← Back to Search
Serious Game Intervention for Breast and Gynecologic Cancers
Study Summary
This trial is testing whether the game can teach self-advocacy skills to women with metastatic breast or advanced gynecologic cancer, which may help them manage their quality of life concerns and cancer- and treatment-related symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am female.I was diagnosed with late-stage gynecological or breast cancer recently and am not being treated for a cure.You have a mental health disorder that is not stable or controlled.Your doctor believes you will live for at least 6 more months.I am currently receiving hospice care.I am 18 years old or older.I am mostly active and can care for myself.
- Group 1: Serious game intervention
- Group 2: Enhanced care as usual
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What objectives is this research attempting to accomplish?
"This trial will assess a variety of objectives over the span of Baseline and 3 months, such as measuring changes in self-advocacy scores on the Female Self-Advocacy in Cancer Survivorship (FSACS) Scale at 6 months. Secondary goals include shifts in patient-perceived patient-centeredness of care ratings registered by the Patient Centeredness of Care Scale (PCCS) at 3 months - which is an 14 item 4 point Likert type scale with a score range from 0 to 42 - and alterations in quality of life indices tracked using the Functional Assessment for Cancer Therapy General (FACT G)"
Are people still able to enroll in this scientific trial?
"According to the information on clinicaltrials.gov, this research project is actively accepting applicants and has been since August 22nd 2022 when it was first posted. It was last revised on the same date as well."
How many participants can be admitted to the trial?
"That is correct. In accordance with the information provided on clinicaltrials.gov, this investigation was first announced on August 22nd 2022 and remains open for enrollment today. The trial requires 336 participants from 1 site to participate in order to be completed successfully."
Share this study with friends
Copy Link
Messenger